Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by hobbs2969on Dec 03, 2021 9:00am
211 Views
Post# 34193992

Good Article on MedX at Investor Intel

Good Article on MedX at Investor IntelIt was posted Nov. 23,2021 but gives a positive overview. The only disconcerting portion was close to the end of the article.

"With a current market cap of roughly $16 million, there is a lot of leverage to increased revenue. However, with a quarterly burn rate of $1.0-$1.5 million and only $1.8 million of cash available at the end of Jun/21 MedX could be requiring a capital raise in short order."

Being that the article was posted on Nov. 23,2021, I wondered if that date should have June 2022 or Jun/22 as they have written. I have contacted Investor Intel for clarification.

You can read the article at:


https://investorintel.com/markets/biotech-healthcare/biotech-intel/medx-healths-siascopy-the-future-of-remote-dermatological-diagnosis-has-arrived/



 
<< Previous
Bullboard Posts
Next >>